The #ReleaseMyMeds campaign aims to provide support for those patients prescribed medicinal cannabis in the UK.
Following the landmark legislative change in Germany earlier this month, experts are expecting to see a ripple effect across the continent.
The founder of the International Alliance for Cannabinoid Medicine (IACM) on finding a new purpose following his own personal health struggles.
Researchers analysed data from 4,744 US adults aged 45 and older.
Researchers have highlighted the need for greater public health messaging around the risks of cannabis use disorders.
Nathan Williams was pulled over by the same police officer just months after a previous case against him was dismissed.
PTSD symptoms significantly reduced three months after starting treatment with cannabis-based medicines.
Early economic analysis suggests that at the right price point, cannabis-based medicines could offer a cost-effective alternative for chronic pain.
Greece was among the first in Europe to legalise medical cannabis in 2017.
The IACM Patient Council will highlight the barriers facing cannabis patients across the globe in Vienna next month.